# Safety and Efficacy Study of Intramuscular Uricase-PEG 20

> **NCT01038947** · PHASE1 · UNKNOWN · sponsor: **EnzymeRx** · enrollment: 28 (estimated)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **BIOLOGICAL:** Uricase-PEG 20

## Key facts

- **NCT ID:** NCT01038947
- **Lead sponsor:** EnzymeRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2009-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038947, "Safety and Efficacy Study of Intramuscular Uricase-PEG 20". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT01038947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*